Stay updated on RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial

Sign up to get notified when there's something new on the RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page has removed a significant citation regarding a study on latent pulmonary vascular disease and its impact on heart failure treatment, which was previously included.
    Difference
    0.2%
    Check dated 2025-05-08T10:26:22.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-05-01T05:09:45.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has been updated to include new information about heart failure and a new version revision, while significant details regarding the clinical trial protocol and inclusion/exclusion criteria have been removed.
    Difference
    29%
    Check dated 2025-04-16T14:39:12.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 12, 2025, while a date for March 25, 2025, has been removed.
    Difference
    0.2%
    Check dated 2025-04-09T09:32:50.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, v2.14.3, with the last update date changed to March 25, 2025, replacing the previous date of February 12, 2025.
    Difference
    0.2%
    Check dated 2025-04-01T23:25:12.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.8%
    Check dated 2025-02-24T20:45:28.000Z thumbnail image

Stay in the know with updates to RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial page.